How can you find QUATS that fit your requirements? - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

How can you find QUATS that fit your requirements?

FeF Chemicals is a Novo Nordisk company that specialises in the supply of ingredients for the pharmaceutical and biopharmaceutical industries, such as and cGMP manufactured Quaternary Ammonium Compounds (usually referred to as Quats) e.g. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide and Insulin Human for cell culture media.

For our cGMP manufactured Quats we offer:

  • Global regulatory compliance
  • Manufacture in accordance with the highest GMP standards on the market, the ICH Guide Q7 for Active Pharmaceutical Ingredients
  • High purity products
  • Analyses according to multicompendial pharmacopoeias BP, Ph.Eur., USP/NF and JP
  • Regulatory documentation

As an approved supplier by a large number of global leading pharmaceutical companies, FeF Chemicals can assure full traceability and reliability of the raw materials. We have a well-developed management system, allowing tracing where the raw materials are used. We also have close contact with our suppliers and can meet with customer requested specifications. For us, reliability is not just in the system but also in the mindset of our employees.

Our quality system meets DS/EN ISO 9001 and ICH’s cGMP Guide for Active Pharmaceutical Ingredients (ICH Q7). Uniform quality of finished products is ensured by our efficient quality control systems, computerised materials planning and rigorous laboratory quality control.

If the required product is not in the standard assortment, we can design customized products. Our flexible production process can meet customer demands for special chain length distribution and/or solutions of quats mixed in various ratios.

Contact details:

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here